Unicycive Therapeutics, Inc.

UNCY · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$37-$31-$18-$10
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$2$1$1
Change in WC-$0-$0$1-$0
Other Non-Cash$6$10$0$3
Operating Cash Flow-$29-$18-$16-$6
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0-$0
Financing Activities
Debt Repay.$0$0$0-$0
Stock Issued$1$0$0$22
Stock Repurch.$0$0$0$0
Dividends Paid-$1$0$0$0
Other Fin. Act.$46$28-$0$0
Financing Cash Flow$45$28-$0$22
Forex Effect$0$0$0$0
Net Chg. in Cash$16$9-$16$17
Supplemental Information
Beg. Cash$10$0$17$0
End Cash$26$10$0$17
Free Cash Flow-$29-$18-$16-$6